Disease progression markers during asymptomatic phase of HIV-1 infected children with unimpaired CD4+ cell values: Evaluation of repeat CD4+ cell evaluation vs. other immunological parameters

Journal of Tropical Pediatrics

Volumn 48, Issue 6, 2002, Pages 340-347

  Chattopadhya, D ^a   Baveja, U K ^a   Bose, M ^b   Kumar, A ^c  

^a NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

^b UNIVERSITY OF DELHI   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CYTOKINE; GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DELAYED HYPERSENSITIVITY; DISEASE COURSE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PARAMETERS; LYMPHOCYTE COUNT; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RELIABILITY; SYMPTOMATOLOGY; T LYMPHOCYTE; TH1 CELL; TH2 CELL; THALASSEMIA MAJOR;

BETA-THALASSEMIA; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; INDIA; INTERFERON TYPE II; INTERLEUKIN-2; PROSPECTIVE STUDIES;

EID: 0036910952     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/48.6.340     Document Type: Article

References (32)

1. Aronstam A, Congard B, Evans DIK, et al. HIV infection in haemophilia in a European cohort. Arch Dis Child 1993; 68: 521-24.
2. Darby SC, Rizza CR, Doll R, et al. Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the UK. BMJ 1989; 298: 1064-68.
3. Pizzo PA, Wilfert CM and the Paediatric AIDS Sienna Workshop II. Markers and determinants of disease progression in children with HIV infection. J Acquir Immune Defic Syndr 1995; 8: 30-44.
4. Peterson J, Church J, Gowperts E, Parkman R. Lymphocyte phenotype does not predict immune function in paediatric patients infected with human immunodeficiency virus type-1. J Pediatr 1989; 115: 944-50.
5. 6/L. AIDS 1995; 9: 145-52.
6. Leibovitz E, Rigand M, Pollack H, et al. Pneumocystis carinii pneumonia in infants infected with the human immunodeficiency virus with more than 450 CD4 T lymphocytes per cubic millimeter. N Eng J Med 1990; 323: 531-33.
7. Chattopadhya D, Aggarwal R, Prakash C, Sen, Kumari S. Sexually transmitted disease (STD) markers in multitransfused children in relation to human immunodeficiency virus type-1 infection-impact of STD markers in blood donors. J Trop Ped 1997; 43: 178-81.
8. CDC revised classification system for Human Immunodeficiency Virus infection in children less than 13 years of age. MMAR 1994; 43: 1-10.
9. Sen S, Mishra NM, Giri T, et al. Acquired immunodeficiency syndrome (AIDS) in multitransfused children with thalassemia. Ind Ped 1993; 30: 455-60.
10. Corriel RN, Kniker WT, McBryde JL, Leonard BM. Cell mediated immunity in school children assessed by multicell skin testing; normal values and proposed scoring system for healthy children. Am J Dis Child 1985; 139: 141-46.
11. Ashton LJ, Carr A, Cunningham PH, et al. Predictors of long term nonprogressor. AIDS Res Hum Retrovir 1998; 14: 117-21.
12. Armitage P, Berry C. Statistical Methods in Medical Research, 3rd edn. Blackwell Scientific Publications, Oxford, 1994.
13. Torre D, Zeroli C, Giola M, et al. Serum levels of interleukin -1α, interleukin -1β, interleukin 6 and tumour necrosis factor in patients with acute vital hepatitis. Clin Infect Dis 1994; 18: 194-98.
14. Dickover RE, Dillon M, Gillette SG, et al. Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis 1994; 170: 1279-84.
15. Munoz Fernandez MA, Obregon E, Navarro J, et al. Relationship of virologic, immunologic and clinical parameters in infants with vertically acquired human immunodeficiency virus type-1 infection. Pediatr Res 1996; 401: 597-602.
16. European Collaborative Study. Age related standards for T lymphocyte subsets based on infected children born to human immunodeficiency virus -1 infected women. Pediatr Infect Dis J 1992; 11: 1018-26.
17. Erkeller-Yuksel FM, Deneys V, Yuksel B, et al. Age related changes in human blood lymphocyte subpopulations. J Pediatr 1992; 120: 216-22.
18. Phair J, Jacobson L, Detels R, et al. Acquired immunodeficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the multicentric AIDS cohort study. J Acquir Immune Defic Syndr 1992; 5: 490-96.
19. Simicco A, Fora R, Scindra N, Lucchini A, Caramello P, Gioannini P. Risk of developing AIDS after primary acute HIV-1 infection. J Acquir Immune Defic Syndr 1993; 6: 575-81.
20. Keet IPM, Krol A, Klein MR, et al. Characteristics of long term asymptomatic infection with human immunodeficiency virus type-1 in men with normal or low counts. J Infect Dis 1994; 169: 1236-43.
21. Skowron G, Cole BF, Zheng D, Accetta G, Lieberman BY. gp 120-directed antibody dependent cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV-1 disease. AIDS 1997; 11: 1807-14.
22. Donegan E, Stuart M, Niland JC, et al. Infection with human immunodeficiency virus type-1 (HIV-1) among recipients of antibody positive blood donations. Ann Intern Med 1990; 113: 733-39.
23. Yadav S, Chattopadhya D, Prakash C, Kumari S, Verghese T. Role of transfusion mediated viral infections on the lymphocyte subset profile in multitransfused children. J Trop Ped 1993; 39: 243-50.
24. Blatt SP, Hendrix CW, Butzin CA, et al. Delayed type hyper-sensitivity skin testing predicts progression to AIDS in HIV infected patients. Ann Intern Med 1995; 119: 177-84.
25. + T cell count, in vitro T helper cell function, and spinal fluid IgG parameters in 163 neurologically normal adults infected with the human immunodeficiency virus type-1. J Infect Dis 1991; 163: 971-75.
26. Ascher MS, Shepperd HW. AIDS as immune system activation: a model for pathogenesis. Clin Exp Immunol 1988; 73: 165-67.
27. Moss AR, Bacchetti S, Osmond D, et al. Seropositivity for HIV and the development of AIDS or AIDS related condition. Three year follow up of the San Francisco General Hospital Cohort. BMJ 1988; 296: 745-50.
28. 2 model of HIV infection: New insights. Immunol Today 1994; 15: 575-81.
29. Clerici M, Balotta C, Meroni L, et al. Type 1 cytokine production and low prevalence of viral isolation correlate with long term nonprogression in HIV infection. AIDS Res Hum Retrovir, 1996; 12: 1053-61.
30. Meroni L, Trabattoni D, Balotta C, et al. Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection. AIDS 1996; 10: 23-30.
31. Shearer GM, Clerici M. Early T-helper cell defects in HIV infection. AIDS 1991; 5: 245-53.
32. + T helper cell depletion occurs. J Clin Invest 1988; 82: 1908-16.